Chembio Files Patent Application for New Rapid Test Platform; Innovative Lateral Flow Technology Drives Improved Performance.MEDFORD, N.Y. -- Chembio Diagnostics, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : CEMI CEMI Center for Experimental Music and Intermedia (University of North Texas, Denton, TX) CEMI Communications-Electronics Maintenance Instruction ) announced today that it has filed a new patent application with the United States Patent and Trademark Office The United States Patent and Trademark Office (PTO or USPTO) is an agency in the United States Department of Commerce that provides patent protection to inventors and businesses for their inventions, and trademark registration for product and intellectual property for a novel method and device incorporating lateral flow technology, which the company believes provides it with a proprietary platform upon which it will be able to develop several new rapid tests. The company believes that by having its own proprietary platform, and one which represents a significant departure from existing lateral flow technology, it will facilitate plans for developing new cost-effective rapid tests that have improved performance features. "We are committed to the continued development of innovative rapid diagnostic test solutions," said Lawrence A. Siebert, President of Chembio. "The product development, manufacturing, and technology transfer agreements that we have in place today with leading organizations such as Bio-Manguinhos and Prionics are a result of our experience and know-how in the area of lateral flow technology. This patent application represents the ingenuity of our development team as well as their knowledge of the limitations of current technologies. We will be working hard during 2005 to complete our initial product offerings utilizing these as well as other innovations." ABOUT CHEMBIO Chembio Diagnostics, Inc. (Chembio) possesses expertise in the development and manufacturing of rapid test products for various indications, including HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. , Tuberculosis tuberculosis (TB), contagious, wasting disease caused by any of several mycobacteria. The most common form of the disease is tuberculosis of the lungs (pulmonary consumption, or phthisis), but the intestines, bones and joints, the skin, and the genitourinary, and BSE See Bombay Stock Exchange. BSE See Boston Stock Exchange (BSE). (a.k.a. Mad Cow Disease mad cow disease: see prion. mad cow disease or bovine spongiform encephalopathy (BSE) Fatal neurodegenerative disease of cattle. Symptoms include behavioral changes (e.g. ). Chembio Diagnostic Systems, Inc. is a wholly-owned subsidiary of Chembio Diagnostics, Inc. References to Chembio Diagnostics, Inc may actually refer to Chembio Diagnostic Systems, Inc., the 100%-owned subsidiary of Chembio Diagnostics, Inc. Chembio is located at 3661 Horseblock Road, Medford, NY 11763. Chembio's telephone number is 631-924-1135. Email can be directed to info@chembio.com. Additional information can be found at www.chembio.com. FORWARD-LOOKING STATEMENTS forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the Company's ability to obtain additional financing and the demand for the Company's products. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof here·of adv. Of this. hereof Adverb Formal or law of or concerning this Adv. 1. hereof - of or concerning this; "the twigs hereof are physic" or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC") |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion